Marex Group’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Marex Group's BCAT Position: Q1 2026 in Review
Marex Group sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 39,300 shares — an estimated $556K sold.
Marex Group first reported a position in BCAT in Q2 2024 and held it in 2 quarters. The position peaked at $556K in Q4 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Marex Group reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
- Marex Group sold 39,300 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $556K.
- Marex Group first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and held it in 2 quarters.
- Marex Group's BlackRock Capital Allocation Term Trust position peaked at $556K in Q4 2025.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.